News
15h
Axios on MSNPerimenopausal women are fueling the GLP-1 boom: new dataAxios Visuals Women are being prescribed GLP-1 weight-loss drugs at higher rates than men, new data shows. Why it matters: This is another cultural moment when women, especially those approaching ...
Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...
Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results